GRAIL Inc. (GRAL)
NASDAQ: GRAL
· Real-Time Price · USD
32.16
-2.10 (-6.13%)
At close: May 06, 2025, 3:59 PM
32.23
0.22%
Pre-market: May 07, 2025, 05:55 AM EDT
-6.13% (1D)
| Bid | 32.2 |
| Market Cap | 1.14B |
| Revenue (ttm) | 125.59M |
| Net Income (ttm) | -2.03B |
| EPS (ttm) | -63.54 |
| PE Ratio (ttm) | -0.51 |
| Forward PE | -1.9 |
| Analyst | Hold |
| Ask | 33 |
| Volume | 1,128,865 |
| Avg. Volume (20D) | 1,520,255 |
| Open | 33.00 |
| Previous Close | 34.26 |
| Day's Range | 31.39 - 34.10 |
| 52-Week Range | 12.33 - 63.99 |
| Beta | 4.59 |
About GRAL
GRAIL, Inc., a biotechnology company, focuses on developing technologies for early cancer detection. The company develops Galleri, a screening test for asymptomatic individuals over 50 years of age; and DAC, a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients for whom there is a clinical suspicion of cancer. It is also developing minimal residual disease and other post-diagnostic tests. The company was incorporated ...
Industry Medical - Diagnostics & Research
Sector Healthcare
IPO Date Jun 12, 2024
Employees 1,000
Stock Exchange NASDAQ
Ticker Symbol GRAL
Website https://grail.com
Analyst Forecast
According to 3 analyst ratings, the average rating for GRAL stock is "Hold." The 12-month stock price forecast is $26, which is a decrease of -19.15% from the latest price.
Stock Forecasts2 months ago
-14.72%
GRAIL shares are trading lower. The company report...
Unlock content with
Pro Subscription
2 months ago
-9.2%
GRAIL shares are trading higher after the company reported a year-over-year increase in Q4 financial results.
